Lmcg Investments LLC Sells 2,501 Shares of Doximity, Inc. (NASDAQ:DOCS)

Lmcg Investments LLC decreased its position in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 149,934 shares of the company’s stock after selling 2,501 shares during the period. Lmcg Investments LLC owned approximately 0.08% of Doximity worth $8,005,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. increased its holdings in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the last quarter. Farther Finance Advisors LLC grew its position in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after acquiring an additional 603 shares in the last quarter. Quarry LP increased its stake in Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares during the last quarter. Morse Asset Management Inc purchased a new stake in Doximity during the third quarter valued at approximately $46,000. Finally, GAMMA Investing LLC lifted its stake in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after purchasing an additional 412 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Stock Up 1.1 %

NASDAQ:DOCS opened at $53.78 on Tuesday. The stock has a market capitalization of $10.04 billion, a PE ratio of 59.03, a price-to-earnings-growth ratio of 4.25 and a beta of 1.38. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The stock’s 50-day moving average price is $53.57 and its 200-day moving average price is $42.85.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several recent research reports. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and increased their price target for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. Mizuho started coverage on Doximity in a report on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 price objective for the company. Evercore ISI raised their target price on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. The Goldman Sachs Group assumed coverage on Doximity in a research report on Friday, November 15th. They set a “neutral” rating and a $58.00 price target on the stock. Finally, KeyCorp decreased their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Thirteen investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Doximity has a consensus rating of “Hold” and a consensus target price of $53.12.

View Our Latest Stock Report on DOCS

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Recommended Stories

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.